Overactive Bladder in Children: BeDry Study

We are testing solifenacin, mirabegron, and their combination for treating daytime urinary incontinence in children aged 5 to 14. The study aims to see how well these treatments work and their effects on safety and quality of life.

3-6 monthsConfirmation phase (III)No PlaceboStandard MedicinesOralPediatricsUrology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Betmiga
Betmiga is a medicine used to treat overactive bladder by reducing urgency, frequency, and leakage.
Mirabegron
Mirabegron is a medicine used to treat overactive bladder by reducing urgency, frequent urination, and accidental urine leakage.
Solifenacin Krka
Solifenacin Krka is a medicine used to treat overactive bladder by reducing sudden urges to urinate, frequent bathroom trips, and urine leakage.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Mirabegron
Mirabegron is a substance that relaxes bladder muscles to reduce urinary urgency, frequency, and incontinence.
Solifenacin
Solifenacin is a substance that helps reduce bladder spasms, urgency, and frequent urination in people with overactive bladder.
Solifenacin Succinate
Solifenacin succinate is a substance that relaxes bladder muscles to reduce urgency, frequency, and urinary leakage from an overactive bladder.

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Adablok
Afenix
Anturin

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Aalborg University Hospital
Pediatric and Adolescent Medicine
Aalborg, Denmark
Region Midtjylland
Pediatric and Adolescent Medicine
Århus, Denmark
Esbjerg Sygehus
Pediatric and Adolescent Medicine
Esbjerg, Denmark
Sponsor: Region Midtjylland
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.